Americans Killed Each Other On The Road A Little Less Often In 2025

Why It Matters

Reduced traffic fatalities lower societal costs and signal effective safety interventions, while any reversal could erode decades of progress.

Key Takeaways

• 2025 deaths 36,640, down 6.7% from 2024.
• Miles driven rose 0.9% to 29.8 billion.
• Fatality rate 1.10 per 100 M VMT, best since 2014.
• Fourth consecutive year of declining traffic fatalities.
• Risk of reversal if gas prices and risky driving rise.

Pulse Analysis

The 2025 traffic‑safety report underscores a rare positive shift in U.S. road outcomes. After pandemic‑induced spikes, fatalities have fallen for four straight years, bringing the death toll close to the 2019 baseline. The decline occurred even as vehicle miles traveled increased, suggesting that improvements are not merely a byproduct of reduced traffic volume but stem from deeper changes in driver behavior, vehicle technology, and roadway engineering.

Key contributors to the downward trend include broader adoption of advanced driver‑assistance systems, stricter enforcement of impaired‑driving laws, and targeted infrastructure projects such as median barriers and pedestrian‑friendly streets. State and local safety advocates have leveraged data‑driven campaigns to prioritize high‑risk corridors, while federal funding for Vision Zero initiatives has accelerated deployment of connected‑vehicle communications. Together, these measures have compressed the fatality rate to 1.10 deaths per 100 million VMT, a metric not seen since 2014.

Looking ahead, the gains remain fragile. Rising fuel prices could suppress travel, but they may also provoke risk‑taking behaviors reminiscent of the early pandemic era. Policymakers must therefore reinforce education, expand low‑speed zones, and incentivize electric‑vehicle adoption, which often pairs with smarter telematics. Maintaining the current trajectory could push annual deaths below 34,000 by 2026, aligning road safety with pre‑pandemic norms and delivering substantial economic and public‑health benefits.